Laurent This larger transcript from the interview reaffirms my original interpretation that Amarin will be presenting their own data. My hopes are back up that it may be the AA:EPA ratio data needed to reinforce positive RESPECT data.
“We are going to have new data submitted at AHA to ensure that we keep supporting the evidence behind VASCEPA."